Evidence map›Paper›PMID 40259679›Full record

ArticleMuscle & nerve2025

The Impact of Brain-Derived Neurotrophic Factor rs6265 (Val66Met) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy-Genotype Interactions.

Jordan B Walters, Maria J Quezada, Suning He, Ciara S Haynes, Kathy Steece-Collier, Timothy J Collier, Caryl E Sortwell, Colin K Franz

Abstract read
In one paragraph

Article in Muscle & nerve, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jordan B WaltersRegenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, Illinois, USA.
Maria J QuezadaRegenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0001-9120-4970
Suning HeRegenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, Illinois, USA.
Ciara S HaynesRegenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, Illinois, USA.
Kathy Steece-CollierDepartment of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
Timothy J CollierDepartment of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
Caryl E SortwellDepartment of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
Colin K FranzRegenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, Illinois, USA.

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
Therapeutic Electrical Stimulation Using Wireless, Resorbable Implants to Accelerate Diaphragm Muscle Reinnervation after Phrenic NeuropathyR01NS136683 · NINDS · REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB · PI Colin Franz · 2024 to 2026
$2.0M
American Neuromuscular FoundationBelle Carnell Regenerative Neurorehabilitation FundNCI NIH HHS P30 CA060553NIH HHS R01NS136683NINDS NIH HHS R01 NS136683
6 · The paper itself

Abstract

INTRODUCTION/

aimsTherapeutic electrical stimulation (TES) shows promise in enhancing nerve regeneration, but outcomes vary widely. This study investigates the impact of the rs6265 single nucleotide polymorphism (SNP) on TES efficacy in a preclinical rat model and human stem cell-derived motor neurons.

methodsWild-type (WT) and rs6265 variant rats underwent sciatic nerve transection and received either TES or sham treatment. Muscle reinnervation was assessed through compound muscle action potentials and muscle fiber cross-sectional area. Isogenic human iPSC-derived motor neurons were used to study activity-dependent brain-derived neurotrophic factor (BDNF) secretion.

resultsWT rats that received TES (WT Estim) showed improved muscle cross-sectional area, electrophysiological muscle reinnervation, muscle fiber size, and NMJ reinnervation compared to Sham [p = 0.0468, p < 0.0001, p = 0.0160, p < 0.0001, respectively]. In contrast, rs6265 allele carriers did not experience a benefit of TES (rs6265 Estim) when compared to the Sham treatment [p = 0.9754, p = 0.8606, p = 0.9815, p = 0.1047, respectively]. Additionally, rs6265 allele carriers exhibited impaired activity-dependent BDNF secretion in vitro. DISCUSSION: The rs6265 polymorphism influences TES efficacy, highlighting the need for personalized approaches in peripheral nerve injury (PNI) treatment. These findings suggest that genetic screening could optimize therapeutic outcomes. Understanding genetic factors affecting TES response can enhance treatment strategies for PNI, potentially improving patient recovery and reducing outcome variability.

Indexed as

Brain-Derived Neurotrophic FactorElectric Stimulation TherapyNerve RegenerationPeripheral Nerve InjuriesPolymorphism, Single NucleotideAction PotentialsAnimalsFemaleGenotypeHumansInduced Pluripotent Stem CellsMaleMotor NeuronsRatsRats, Sprague-DawleySciatic NerveBDNF protein, humanBrain-Derived Neurotrophic FactorBDNF rs6265BDNF Val66Metnerve regenerationperipheral nerve injurytherapeutic electrical stimulation

Identifiers

PMID40259679
PMCPMC12138492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.